BASF resolves New Zealand patent dispute against Sledge 700WG – a saflufenacil-based herbicide

BASF SE has settled a patent dispute against Adria New Zealand Limited, in relation to the product Sledge 700WG. The parties have resolved the dispute without any admissions of liability, and Adria New Zealand Limited has removed Sledge 700WG from sale in New Zealand.

Saflufenacil is the active ingredient in BASF’s Kixor^® technology, contained within Sharpen® Herbicide and Voraxor^® Herbicide, amongst other BASF brands globally. Its key applications provide effective solutions against difficult to manage weeds across a range of crop systems worldwide.

 ″BASF strives to support Australian and New Zealand growers by providing them with cutting edge chemistry and technology,″ said Parvana Wali, Head of BASF Agricultural Solutions, Australia and New Zealand.

″In 2023 alone, BASF’s Agricultural Solutions division invested €944 million in R&D, which shows our commitment to farmers and the future of sustainable agriculture. Therefore, we must protect our innovations to the fullest of our capabilities.″

BASF continues to monitor crop protection products around the world, and is prepared to take action, as necessary, to enforce its patent rights and to ensure that only the highest quality ingredients are present in Australia and New Zealand’s top brands and formulations.